3 results match your criteria: "Canada. psbunting@ottawahospital.on.ca[Affiliation]"
Laboratory survey of prostate-specific antigen testing in Ontario updated.
Clin Biochem
May 2004
Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
Effect of a controlled feedback intervention on laboratory test ordering by community physicians.
Clin Chem
February 2004
Gamma-Dynacare Medical Laboratories, Brampton, Ontario, Canada.
Background: Most studies of interventions to reduce laboratory test utilization have occurred in academic hospital settings, used historical controls, or have had short post intervention follow-up. Interventions with the greatest impact use multiple approaches, are repeated regularly, include comparisons with physician peers, and have a personal approach. We determined whether laboratory test utilization by community physicians could be reduced by a multifaceted program of education and feedback.
View Article and Find Full Text PDFIntraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation.
Clin Biochem
September 2002
Department of Clinical Pathology, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.
Objective: To determine the intraindividual variation of prostate-specific antigen (PSA) isoforms in prostate cancer patients managed conservatively with watchful observation.
Methods: Patients with favorable clinical parameters (stage T1b-T2b N0 M0, Gleason score View Article and Find Full Text PDF